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Summary: Diphenhydramine has been in medical use for 35 years äs an antihistamine and hypnotic. We
evaluated the pharmacokinetic parameters, which are not only important for disposition studies, in the serum
of 10 volunteers who received a single dose of 31 mg diphenhydramine.
For this purpose a suitable capillary GC-method was developed, which has a detection limit of 2 §/1 (serum);
the calibration curve is linear between 2.5 and 120 g/l, the reproducibility is always better than 3.6% and the
average recovery is about 100.1%.
The combination of a relatively nofi-polar extraction solvent, a selective detector (N-FID) and a fused silica,
bonded-phase capillary column led to a more rapid sample clean-up procedure (no back-extraction needed)
and is sensitive and specific enough for the quantitative determination of diphenhydramine, orphenadrine or
other ethanolamines in human serum.
Quantitative Bestimmung von Diphenhydramin und Orphenadrin im Serum des Menschen
durch Kapillar-Gaschromatographie
Zusammenfassung: Diphenhydramin findet seit über 35 Jahren als Antihistaminicum und Hypnoticum medi-
zinische Verwendung. Wir bestimmten die nicht nur für pharmakologische Studien wichtigen pharmakokine-
tischen Kenngrößen im Serum von 10 Probanden nach Gabe einer Einzeldosis von 31 mg Diphenhydramin.
Hierzu entwickelten wir eine geeignete kapillar-gaschroinatographische Methode mit einer Nachweisgrenze
von 2 ^g/l Serum; die Kalibrierungskurve ist linear zwischen 2,5 und 120 g/l, die Wiederholbarkeit immer
besser als 3,6% und die Wiederfindungsrate lag bei 100,1%.
Die Kombination eines relativ unpolaren Lösungsmittels zur Extraktion mit einem selektiven Detektor (N-
FID) und einer fused-silica, bonded phase-Kapillare führt, da keine Rückextraktion benötigt wird, zu kürze-
ren Proberiaufbefeitungszeiten und ist empfindlich und spezifisch genug für die quantitative Bestimmung von
Diphenhydramin, Orphenadrin und anderen Ethanolaminen im menschlichen Serum.
Introduction antiemetjc and sedative properties, the last
For well over 35 years diphenydramine hydrochlo- mentioned leading to its widespread use äs a drug for
ride (I)* has been used medicälly äs an antihistamine inducing sleep (2, 3):
and hypnotic (1).
Chemically it is 2-(diphenylmethoxy)-N,N-dimeth-
ylethylamine and possesses anticholinergic, antitus-
* in the U.S.: Benadryl® (Parke-Davis) ^^^
in Germany: Betadorm^-A (Woelm Pharma) Diphenhydramine (I)
in Switzerland: Detensor® (Sandoz)
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Diphenhydramine is rapidly and well absorbed with
a systemic bioavailability of at least 50% after oral
application (4, 5). Maximal plasma concentrations
are reached after one to four hoiirs (6, 7); an appar-
ent plasma half-life of about 3-10 hours is reported
(4).
Average peak plasma levels (after a therapeutic dose
of 50 mg) were about 80-100 [ig/l (3-7). The bio-
transformation of I is well documented in the litera-
ture (8); the major metabolite in human plasma and
urine was identified s diphenylmethoxyacetic acid
(9).
Analytical Methods
Many analytical approaches have been published for the identifU
cation/detection of diphenhydramine, e.g. paper-, thin layer- and
column-chromatography, electrophoresis, colorimetric/fluoro-
metric and titrimetric analysis (10-12). These, however are not
specific and sensitive enough for determinations in biological
fluids (urine, plasma/serum).
The published GC, GC-MS and HPLC-methods are obviously
more reliable. Unfortunately they often include extensive, time
consuming preparations (e.g. special sample clean-up), involving
conversion or formation of derivatives (13) and/or operate near
the limit of sensitivity. Some methods do not distinguish between
the unchanged drug and its metabolites or are prone to interfer-
ences (6).
All the published GC-methods use packed columns and flame
ionization detectors (FID), which limits sensitivity to about
10-20 mg/1 (2, 4, 7, 11, 14); recently published methods employ
more selective detectors, e.g. the nitrogen specific detector (N-
FID) (6).
Vessman et al. (13) successfully used the electron capture detector
(ECD), but their sample clean-up includes e.g. conversion of di-
phenhydramine to benzophenone, a rather time-consuming and
inconvenient procedure. Liquid-chromatographic assays have on^
ly been applied to aqueous samples and/or are not applicable for
rapid (screening) procedures (15, 16). The published gas chroma-
tographic-mass fragmentographic method using single-ion-re-
cording (SIR) of the characteristic ion at m/z 165 fulfills the re-
quirements for a reliable assay but is less suitable for some metab-
olites (e.g. the N-oxide and the diphenylmethoxyacetic acid)
which are either thermolabile or not volatile enough (17, 18); fur-
thermore this method is relatively expensive and often not readily
available in a clinical laboratory.
Results and Biscussion of our own investigations
With some exceptions we followed the GC-method
published by Baugh & Calvert (7); a five-fold in-
crease of the detection limit could be achieved by
employing a capillary column instead of a packed co-
lumn.
Ext rac t ion
To 3 ml of serum in a centrifuge tube (fitted with a teflon lined
cap) 10 μΐ of a methanolic solution of the internal Standard (14
μg/l) are added and thoroughly mixed (Vortex) for 10 seconds.
After adding l ml of sodium hydroxide (l mol/1) and 7 ml /i-hep-
tane, the mixture is extracted for one hour in an Inversion shaker.
After centrifuging, the organic layer is transferred to a coriic l
tube and evaporated to dryness under nitrogen at 55 °C. The re-
sidue is reconstituted in 40 μΐ acetone, concentrated to approx. 10
μΐ and l μΐ is injected in the GC.
GC-condi t ions
The GC analysis is carried out using a Carlo Erba FV 2150 Chro-
matograph equipped with an nitrogen selective detector (N^FID).
Column: 30 m x 0.25 mm fused silica, borided
phase DB-1 capillary column (J + W
Scientific)
Carrier gas: He 1.2 bar
Make-up gas: Na 0.4 bar
Hydrogen: 3 ml/min
Air: 100 ml/min
Ternperatures: injector: 200 °C
oven: 50 °C (l min) to 180 °C for 5 min then at
a rate of 6°C/rnin to 210 °C
The quantitative evaluation of the serum samples was accomp^
lished by comparison with the respective peak area ratios of the
spiked serum samples ("Internal Standard Method").
Figure l a and b show two representative chromato-








Fig. 1. Chromatograms of plasma extracts
a) Drug-free plasma with internal Standard orphenadrine
b) Four hours after receiving 3l· mg diphenydramine
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Figure 2 shows the serum concentration-time curve
of diphenhydramine in 10 volunteers following a sin-
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Fig. 2. Mean serum concentralions (incl. Standard deviation) of
diphenhydramine of 10 volunteers after ingestion of 31
mg.
Conclusions
The presented capillary GC-method allows the fast
and accurate quantitative determination of either di-
phenhydramine or orphenadrine and other ethanol-
amines in human serum. It is also clear from the
chromatogram (fig. 1) that capillary columns provide
more than adequate efficiency, sensitivity and selec-
tivity.
The combination of a rather non-polar extraction
solvent and a selective detector eliminates the need
for e. g. a back extraction or further Steps in sample
clean-up.
A calibration curve was established and checked to
be linear between 2.5 and 120 g/l serum; the detec-
tion limit of 2 g/l clearly shows the reliability of the
assay. Average recovery based on 5 determinations
(at 14 g/l) was about 100.1% (C.V. = 4.9%); re-
producibility between duplicate injections was al-
ways better than 3.6%.
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